Reply to J.J. Boelens et al.

Soiffer, Robert J; Chen, Yi-Bin A; Jagasia, Madan H

Soiffer, Robert J; Chen, Yi-Bin A; Jagasia, Madan H.

Affiliation

Soiffer RJ; Robert J. Soiffer, Dana-Farber Cancer Institute, Boston, MA; Yi-Bin A. Chen, Massachusetts General Hospital, Boston, MA; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.
Chen YA; Robert J. Soiffer, Dana-Farber Cancer Institute, Boston, MA; Yi-Bin A. Chen, Massachusetts General Hospital, Boston, MA; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.
Jagasia MH; Robert J. Soiffer, Dana-Farber Cancer Institute, Boston, MA; Yi-Bin A. Chen, Massachusetts General Hospital, Boston, MA; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

J Clin Oncol ; 36(11): 1176-1177, 2018 04 10.

Article in En | MEDLINE | ID: mdl-29412783

Subject(s)

Globulins; Hematopoietic Stem Cell Transplantation; Disease-Free Survival; Double-Blind Method; Humans; Prospective Studies; T-Lymphocytes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Globulins Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google